Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
Código da empresaAXGN
Nome da EmpresaAxoGen Inc
Data de listagemDec 17, 1986
CEODale (Michael Donald)
Número de funcionários451
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 17
Endereço13631 Progress Blvd.
CidadeALACHUA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal32615
Telefone13864626817
Sitehttps://www.axogeninc.com/
Código da empresaAXGN
Data de listagemDec 17, 1986
CEODale (Michael Donald)
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados